+34.0%
CLSK vs EMR
+15.3%
+18.7%
-64.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.8% | +2.6% | +4.2% | +4.0% |
| 7D | +7.7% | -0.4% | +8.1% | +8.3% |
| 30D | +12.2% | -6.8% | +19.0% | +20.8% |
| 3M | -15.5% | +7.5% | -22.9% | -22.9% |
| 6M | +39.3% | +9.9% | +29.5% | +24.1% |
| YTD | +35.1% | +16.0% | +19.1% | +16.4% |
| 1Y | +34.0% | +12.4% | +21.6% | +15.9% |
| All | +34.0% | +15.3% | +18.7% | +15.9% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling